Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Reexamination Certificate
2006-11-14
2011-10-18
Anderson, James (Department: 1629)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
C514S649000, C514S665000
Reexamination Certificate
active
08039511
ABSTRACT:
A method for preventing and treating prostatic diseases and skin cancer using naturally or artificially synthesized isothiocyanates compounds or the derivatives or metabolites thereof.
REFERENCES:
patent: 2005/0070602 (2005-03-01), Chiao et al.
patent: 2006/0069151 (2006-03-01), Barella et al.
patent: 2010/0204319 (2010-08-01), Archibald
patent: 1724516 (2006-01-01), None
Office Action issued Apr. 8, 2010 in corresponding European Patent Application No. 06817815.1 (6 pages).
Office Action issued Mar. 8, 2010 in corresponding Canadian Patent Application No. 2630262 (4 pages).
Office Communication issued Oct. 15, 2009 in corresponding European Patent Application No. 06817815.1 (2 pages).
English Translation of the Written Opinion of the International Searching Authority of PCT/CN2006/003062, dated Mar. 15, 2007.
English Translation of the International Preliminary Report on Patentability of PCT/CN2006/003062, report completed Mar. 6, 2008.
Wu et al. “An Experimental Study(II) on the Inhibition of Prostatic Hyperplasia by Extract of Seeds ofBrassica alba.” China Journal of Chinese Materia Medica, vol. 28(7), Jul. 2003, pp. 643-646.
Ou et al. “A Brief Review on the Study of Seeds ofBrassica alba.” Strait Pharmaeeutieal Journal, vol. 13(2), 2001, pp. 8-11.
Supplementary European Search Report issued Jul. 31, 2009 by the European Patent Office in Application No. EP 06 81 78015.
Chen et al. “Phenylethyl Isothiocyanate Induces Apoptotic Signaling via Suppressing Phosphatase Activity against c-Jun N-terminal Kinase.” Journal of Biological Chemistry, vol. 277 No. 42, Oct. 18, 2002, pp. 39334-39342.
Srivastava et al. “Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenografts in vivo.” Carcinogenesis, vol. 24 No. 10, Oct. 2003, pp. 1665-1670.
Zuniga et al. “Isothiocyanates inhibit cell growth and induce apoptosis in prostate cancer cells derived from TRAMP mice.” Proceedings of the American Association for Cancer Research Annual Meeting, vol. 43, Mar. 2002, p. 640.
Myzak et al. “Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells.” Carcinogenesis col. 27 No. 4, Apr. 2006, pp. 811-819.
Wang et al. “Repression of androgen receptor in prostate cancer cells by phenethyl isothiocanante.” Carcinogenesis, vol. 27 No. 10, Oct. 2006, pp. 2124-2132.
Office Action Issued for EP Patent Application No. 06 817 815.1-2123, dated Oct. 14, 2010 (5 pages).
International Search Report for International Application No. PCT/CN2006/003062 and English translation thereof, mailed Mar. 2007.
Hecht et al. “Inhibition of lung tumorigenesis in A/J mice byN-acetyl-S-(N-2-phenethylthiocarbamol)-L-cysteine andmyo-inositol, individually and in combination.” Carcinogenesis, 23(9), 2002, p. 1455-1461.
Brooks et al. “Potent Induction of Phase 2 Enzymes in Human Prostate Cells by Sulforaphane.” Cancer Epidemiology, Biomarkers & Prevention, 10, 2001, p. 949-954.
Ye et al., “Total intracellular accumulation levels of dietary isothiocyanates determine their activity in elevation of cellular glutathione and induction of Phase 2 detoxification enzymes.” Carcinogenesis, 22(12), 2001, p. 1987-1992.
Cheng Jingcai
Chiao Jenwei
Jin Haiya
Zhong Chengjuan
Anderson James
Hamre Schumann Mueller & Larson P.C.
Wuxi JC Pharmaceutical Technology Co., Ltd.
LandOfFree
Use of isothiocyanates compounds in treating prostatic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of isothiocyanates compounds in treating prostatic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of isothiocyanates compounds in treating prostatic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4291667